Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes

William A Banks1, Susan A Farr, John E Morley

  • 1GRECC, Veterans Affairs Medical Center, St. Louis, Mo., USA. bankswa@slu.edu

Neuroimmunomodulation
|August 9, 2003
PubMed

Insights

Cytokines like interleukin-1alpha (IL-1alpha) circulating in the blood can impair memory by crossing the blood-brain barrier (BBB). This mechanism involves the posterior division of the septum (PDS) in sickness behavior.

Area of Science:

  • Neuroscience
  • Immunology
  • Physiology

Background:

  • Blood-borne cytokines, such as interleukin-1 (IL-1), significantly influence central nervous system (CNS) functions.
  • Sickness behavior, a common response to infection or inflammation, includes notable impairments in learning and memory.
  • IL-1 is a key mediator of these memory deficits associated with sickness behavior.

Purpose of the Study:

  • To investigate the role of cytokine transport across the blood-brain barrier (BBB) in mediating memory impairments during sickness behavior.
  • To elucidate the specific mechanisms by which interleukin-1alpha (IL-1alpha) affects memory within the CNS.

Main Methods:

  • Review of proposed mechanisms for cytokine action within the CNS.
  • Experimental focus on the transport of cytokines across the BBB.
  • Investigation of the posterior division of the septum (PDS) in IL-1alpha-induced memory effects.

Main Results:

  • The posterior division of the septum (PDS) is identified as a critical region for mediating IL-1alpha's effects on memory.
  • Circulating IL-1alpha directly acts on the PDS to induce memory impairments.
  • The ability of IL-1alpha to cross the BBB is essential for this effect at the PDS.

Conclusions:

  • Cytokine transport across the BBB is a significant mechanism underlying sickness-induced memory impairments.
  • IL-1alpha's passage through the BBB and subsequent action on the PDS are key to its detrimental effects on memory.
  • Targeting BBB transport or PDS activity may offer therapeutic avenues for cognitive deficits during illness.